Search results (123)
« Back to NewsTheolytics Limited comes out of stealth mode with Dr Ken Powell announced as Chair of the Board
25 June 2019
Virology spinout Theolytics emerges from stealth with £2.5m seed and Dr Ken Powell as chair.
PepGen receives a £1.6M grant from Innovate UK
2 November 2018
PepGen has been awarded a grant of £1.6 M from Innovate UK, the UK’s innovation agency. The company’s project, entitled ‘Application of a novel peptide delivery platform to nucleic acid therapeutics in degenerative and rare diseases’, will run for 20 months, and this funding will be instrumental in supporting the pre-clinical development of PepGen’s innovative technology.
First tenant moves into the BioEscalator
10 September 2018
PepGen is a biotech company that focuses on peptide-mediated delivery of nucleic acids.